Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

NCT: NCT05839535 · RECRUITING

NCT IDNCT05839535
StatusRECRUITING
Start Date2024-03-05
Completion2028-08-31
SponsorMassachusetts General Hospital (OTHER)
First posted
Last updated

Brief Summary

This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.

Frequently Asked Questions

What is Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA?

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA is a clinical trial registered under NCT05839535. Current status: RECRUITING.

What is the status of NCT05839535?

The current status of NCT05839535 (Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA) is: RECRUITING.

When did Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA start?

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA started on 2024-03-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.